Case ReportIndian Journal of Pharmacy PracticeVol. 12 | Issue 2 | 2019 | pp. 129–132Open access
A Case Report on Diclofenac Induced Chronic Kidney Disease
- 1*,
- 1,
- 1,
- 1,
- 1,
- 1
- 1 Department of Pharmacy Practice, Basveshwar Teaching and General Hospital, HKES's Mathoshree Taradevi Rampure Institute of Pharmaceutical Sciences. Kalaburagi, Karnataka, INDIA.
Published in Indian Journal of Pharmacy Practice
Correspondence: Vanishree Prakash Babladi
Department of Pharmacy Practice, Basveshwar Teaching and General Hospital, HKES's Mathoshree Taradevi Rampure Institute of Pharmaceutical Sciences. Kalaburagi, Karnataka, INDIA.
Email: vanibalpb@gmail.com
Copyright: © 2019 Manuscript Technomedia. This is an open access article.
- Published:
- Apr 17, 2019
How to cite
Babladi, V. P., Patil, N., G, M., Salimath, P. V., Ninne, S. R., & Chary, K. M. (2019). A Case Report on Diclofenac Induced Chronic Kidney Disease. Indian Journal of Pharmacy Practice, 12(2), 129–132. https://doi.org/10.5530/ijopp.12.2.27
Abstract
Non-steroidal Anti-inflammatory Drugs (NSAID) are one of the most commonly prescribed drugs and their nephrotoxic effects are well known. Diclofenac is one of the Non-steroidal anti-inflammatory drugs that exert anti-inflammatory, analgesic and antipyretic effects through the suppression of Prostaglandin (PG) synthesis, by inhibiting the enzyme Cyclooxygenase (COX). The most important mechanism of anti-inflammatory action of Non-steroidal anti-inflammatory drugs is considered to be inhibition of Cyclooxygenase-2 (COX-2) mediated enhanced prostaglandin synthesis at the site of injury. A 65-year male case was admitted with chief complaints of bilateral lower limb swelling and facial swelling. The patient history revealed that he had taken Tab. Diclofenac in combination with Paracetamol [acetaminophen] for almost one year. The final diagnosis was made as drug induced Chronic Kidney Disease (CKD), Hypertension (HTN), bilateral lower limb cellulitis and anemia. In this case, kidney disease and overuse of Diclofenac may account for the increase in blood pressure [hypertension]. The treatment was given accordingly after 7 days of hospital stay the patient had recovered and was given discharge.
Keywords
Subject
Article metadata
| Title | A Case Report on Diclofenac Induced Chronic Kidney Disease |
|---|---|
| Authors | Vanishree Prakash Babladi; Neelkanthreddy Patil; Manjunath G; Pooja V Salimath; Sheetal R Ninne; K Mukteshwara Chary |
| Affiliations | Department of Pharmacy Practice, Basveshwar Teaching and General Hospital, HKES's Mathoshree Taradevi Rampure Institute of Pharmaceutical Sciences. Kalaburagi, Karnataka, INDIA. |
| Corresponding author | vanibalpb@gmail.com |
| Journal | Indian Journal of Pharmacy Practice |
| Volume / Issue | Vol. 12, Issue 2 (2019) |
Also in this issue
- Clinical Data Analysis: A Challenging Career Option to Clinical Pharmacy Studentspp. 65
- Clinical Effects of Edaravone in Stroke: A Reviewpp. 66–69
- Strengthening Medication Adherence Practices in Chronic Disease Patients-Clinical Pharmacist Driven Focused Approachpp. 70–76
- Insulin Therapy in Type-II Diabetes Mellitus – Is it Feasible and Acceptable?pp. 77–83
- Pharmacoeconomic Analysis and Treatment Pattern in Sepsis Patients: A Cross-sectional Prospective and Retrospective Studypp. 84–91
Readers Also Viewed
Development and Validation of UV/visible Spectrophotometric Method for Estimation of Piroxicam from Bulk and Formulation
Sandip Mohan Honmane, Kunal Rajaram Yadav, Yuvraj Dilip Dange
Apr 23, 2025
Effects of Artificial Intelligence on Academic Performance of Library and Information Science University Students: A Meta-Analysis (2023-2025)
Kayode Sunday John Dada
Aug 6, 2026
Bridging Innovation and Impact: A Multidisciplinary Approach to Contemporary Research Challenges
Mueen Ahmed KK
Aug 11, 2026